Related Experiment Video
Updated: Apr 16, 2026

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
Published on: March 31, 2016
Refractory hypokalemia during barbiturate coma therapy used for treating refractory intracranial hypertension in
Wan Mohd Nazaruddin Wan Hassan1, Nazuha Mohd Najid1, Halimatun Sa'adiah Muslim1
1Department of Anaesthesiology, School of Medical Sciences and P3 Neuro Center, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Insights
Barbiturate coma therapy can cause dangerous low potassium levels. This case report details managing this rare complication in a patient undergoing thiopentone treatment for high intracranial pressure.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Pharmacology
Background:
- Barbiturate coma therapy (BCT) is a critical intervention for refractory intracranial hypertension (ICP) when standard treatments fail.
- BCT effectively reduces cerebral blood flow, oxygen consumption, and ICP.
- However, BCT is associated with significant complications, including electrolyte imbalances.
Observation:
- Refractory hypokalemia (low potassium) is an underreported yet life-threatening complication of BCT.
- This complication can paradoxically lead to hyperkalemia (high potassium) upon abrupt discontinuation of the therapy.
- We present a case of managing refractory hypokalemia during thiopentone-induced BCT in a patient who underwent decompressive craniectomy.
Findings:
- The patient developed persistent hypokalemia requiring intensive management.
- Careful monitoring and electrolyte correction were crucial to prevent rebound hyperkalemia.
- Successful management involved a tailored approach to BCT and potassium replacement.
Implications:
- Highlights the importance of vigilant electrolyte monitoring during BCT.
- Suggests a need for standardized protocols for managing hypokalemia in patients receiving BCT.
- Informs clinical practice regarding the safe use of thiopentone for intracranial pressure management.
Abstract:
Barbiturate coma therapy (BCT) is a choice treatment for refractory intracranial hypertension after all surgical or medical managements have failed to control the intracranial pressure (ICP). It helps to reduce cerebral blood flow, cerebral metabolic rate of oxygen consumption and ICP. However, this therapy can also cause many complications. One of the underreported, but life-threatening complications is refractory hypokalemia, which can lead to subsequent rebound hyperkalemia after sudden cessation. We report our experience of managing unusual complication of refractory hypokalemia during BCT with thiopentone in postdecompressive craniectomy patient.
Related Concept Videos
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines
Acute Kidney Injury V: Interprofessional Care
Depolarizing Blockers: Pharmocokinetics
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antihypertensive Drugs: Potassium-Sparing Diuretics

